Celltrion Pharm, Inc. (068760.KQ) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.52T |
| Enterprise Value | 2.63T |
| P/E Ratio | 38.67 |
| PEG Ratio | 1.3 |
| Price/Sales Ratio | 2.88 |
| Price/Book Ratio | 3.73 |
| Enterprise/Revenue | 3.07 |
| Enterprise/EBITDA | 20.63 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.11 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 536.4B |
| Revenue/Share | 12,972.25 |
| Gross Profit | 160.98B |
| EBITDA | 78.34B |
| Net Income | 38.75B |
| Diluted EPS | 891.88 |
Balance Sheet
| Total Cash | 123.82B |
| Total Cash/Share | 2,778.92 |
| Total Debt | 160.15B |
| Total Debt/Equity | 0.36 |
| Current Ratio | 1.71 |
| Book Value Per Share | 10,081.7 |
Price History
| 52-Week Change | -33.57 |
| 52-Week High | 78,300 |
| 52-Week Low | 35,600 |
| Moving Average 50 Days | 40,296 |
| Moving Average 200 Days | 51,102.25 |
Statistics
| Average Volume | 80,685 |
| Shares Outstanding | 44.26M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 200 |
| Trailing Annual Dividend Yield | 0.53 |
| Payout Ratio | 0.2 |
| Last Split Factor | 51:50 |
| Last Split Date | December 29, 2025 |
AD
